Author:
Bilous M,Ades C,Armes J,Bishop J,Brown R,Cooke B,Cummings M,Farshid G,Field A,Morey A,McKenzie P,Raymond W,Robbins P,Tan L
Reference29 articles.
1. 1. Slamon D J, Clark G M, Wong S G et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu proto-oncogene. Science 1987; 235: 177–182.
2. 2. Ross J S, Fletcher J A. The HER-2/neu (c-erbB-2) gene and protein in breast cancer. Am J Clin Pathol 1999; 112 (Suppl 1): 553–567.
3. 3. Birner P, Oberhuber G, Stani J et al. Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer. Clin Cancer Res 2001; 7: 1669–1675.
4. 4. Bartlett J M, Going J, Mallon E A et al. Evaluating HER2 amplification and overexpression in breast cancer. J Pathol 2001; 195: 422–488.
5. 5. Kallionemi O-P, Kallioniemi A, Kurisu W et al. ERBB2 amplification in breast cancer analysed by fluorescence in situ hybridisation. Proc Natl Acad Sci USA 1995; 89: 5321–5325.
Cited by
75 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献